Clinical research - Press Releases

Date	Title	Company
09-Nov-2023	Elsevier introduces authoritative scientific Datasets to fuel innovation and business-critical decisions in life sciences, chemicals and other research-intensive industries	Elsevier
09-Nov-2023	New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis	TREMFYA
07-Nov-2023	Futura expands partnership with M8 Pharmaceuticals for remainder of Central and South American region	Futura Medical plc
07-Nov-2023	Sosei Heptares’ President & CEO and Head of UK R&D to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2023	Sosei Heptares
07-Nov-2023	World’s first smart breathing tube for mechanically ventilated patients set for human trials	University of Nottingham
07-Nov-2023	ABB conveyor drive technology will enable LKAB underground mine to significantly increase energy efficiency	ABB Ltd
07-Nov-2023	Life Sciences event at Chelsea and Westminster Hospital	CW+
31-Oct-2023	Nouscom’s Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to ‘Intercept’ Cancer in Subjects with Lynch Syndrome	Nouscom
31-Oct-2023	Aqilion reports positive results from the ARIA-1 Phase 1 study in healthy subjects	Aqilion
30-Oct-2023	CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules	CD Bioparticles
26-Oct-2023	Phastar Offers Pro Bono Support to Medicines Development for Global Health	Phastar
26-Oct-2023	Kancera reports that the phase I study of KAND145 has received regulatory approval	Kancera AB
26-Oct-2023	Mtech Access are returning to ISPOR Europe this November	Mtech Access
26-Oct-2023	Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth	Centricity Research
24-Oct-2023	ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002	ImmunOs Therapeutics
23-Oct-2023	KITE’S CAR T-CELL THERAPY YESCARTA® (AXICABTAGENE CILOLEUCEL) COMPARED WITH BISPECIFICS IN R/R DLBCL IN TWO ANALYSES AT ESMO 2023	Kite Pharma
18-Oct-2023	Biomapas Achieves Notable Recognition with Nomination for HSJ Patient Safety Awards 2023	Biomapas
17-Oct-2023	Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells	The Institute of Cancer Research
17-Oct-2023	New publication shows XF-73 drug potent against 2,527 Staphylococcus isolates Largest study of its kind to date demonstrates effectiveness of XF-73 against all tested antibiotic resistant strains	Destiny Pharma
17-Oct-2023	STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	STORM Therapeutics Ltd